Annual EBIT
$978.90 M
-$12.00 B-92.46%
31 December 2023
Summary:
BioNTech SE annual earnings before interest & taxes is currently $978.90 million, with the most recent change of -$12.00 billion (-92.46%) on 31 December 2023. During the last 3 years, it has fallen by -$16.68 billion (-94.46%). BNTX annual EBIT is now -94.46% below its all-time high of $17.75 billion.BNTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$183.34 M
+$1.04 B+121.32%
01 September 2024
Summary:
BioNTech SE quarterly earnings before interest & taxes is currently $183.34 million, with the most recent change of +$1.04 billion (+121.32%) on 01 September 2024. Over the past year, it has dropped by -$222.44 million (-54.82%). BNTX quarterly EBIT is now -96.75% below its all-time high of $5.64 billion, reached on 31 March 2022.BNTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$625.96 M
-$66.43 M-11.87%
01 September 2024
Summary:
BioNTech SE TTM earnings before interest & taxes is currently -$625.96 million, with the most recent change of -$66.43 million (-11.87%) on 01 September 2024. Over the past year, it has dropped by -$1.62 billion (-162.68%). BNTX TTM EBIT is now -102.95% below its all-time high of $21.24 billion, reached on 31 March 2022.BNTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -54.8% | -162.7% |
| 3 y3 years | -94.5% | -96.5% | -103.6% |
| 5 y5 years | +592.1% | +384.0% | -218.6% |
BNTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -94.5% | at low | -96.8% | +121.3% | -103.0% | at low |
| 5 y | 5 years | -94.5% | +592.1% | -96.8% | +121.3% | -103.0% | at low |
| alltime | all time | -94.5% | +592.1% | -96.8% | +121.3% | -103.0% | at low |
BioNTech SE EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $183.34 M(-121.3%) | -$625.96 M(+11.9%) |
| June 2024 | - | -$859.79 M(+142.0%) | -$559.53 M(+278.6%) |
| Mar 2024 | - | -$355.29 M(-187.6%) | -$147.81 M(-114.8%) |
| Dec 2023 | $978.90 M(-92.5%) | $405.78 M(+62.5%) | $998.73 M(-68.3%) |
| Sept 2023 | - | $249.77 M(-155.7%) | $3.15 B(-41.3%) |
| June 2023 | - | -$448.06 M(-156.6%) | $5.37 B(-35.3%) |
| Mar 2023 | - | $791.24 M(-69.1%) | $8.30 B(-36.9%) |
| Dec 2022 | $12.98 B(-26.5%) | $2.56 B(+3.9%) | $13.14 B(-17.0%) |
| Sept 2022 | - | $2.47 B(-0.4%) | $15.83 B(-16.1%) |
| June 2022 | - | $2.48 B(-56.1%) | $18.87 B(-11.2%) |
| Mar 2022 | - | $5.64 B(+7.3%) | $21.24 B(+20.8%) |
| Dec 2021 | $17.66 B | $5.25 B(-4.6%) | $17.59 B(+39.8%) |
| Sept 2021 | - | $5.50 B(+13.5%) | $12.58 B(+84.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $4.85 B(+144.9%) | $6.83 B(+262.6%) |
| Mar 2021 | - | $1.98 B(+705.3%) | $1.88 B(-1325.1%) |
| Dec 2020 | -$164.22 M(-17.4%) | $245.85 M(-201.6%) | -$153.82 M(-66.9%) |
| Sept 2020 | - | -$242.07 M(+144.2%) | -$464.22 M(+82.0%) |
| June 2020 | - | -$99.12 M(+69.5%) | -$255.05 M(+21.9%) |
| Mar 2020 | - | -$58.49 M(-9.4%) | -$209.23 M(+6.5%) |
| Dec 2019 | -$198.93 M(+266.7%) | -$64.55 M(+96.3%) | -$196.47 M(+47.6%) |
| Sept 2019 | - | -$32.89 M(-38.3%) | -$133.11 M(+6.5%) |
| June 2019 | - | -$53.30 M(+16.5%) | -$124.97 M(+74.4%) |
| Mar 2019 | - | -$45.73 M(+3738.9%) | -$71.67 M(+176.3%) |
| Dec 2018 | -$54.25 M(-43.8%) | -$1.19 M(-95.2%) | -$25.94 M(+4.8%) |
| Sept 2018 | - | -$24.75 M | -$24.75 M |
| Dec 2017 | -$96.52 M | - | - |
FAQ
- What is BioNTech SE annual earnings before interest & taxes?
- What is the all time high annual EBIT for BioNTech SE?
- What is BioNTech SE quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BioNTech SE?
- What is BioNTech SE quarterly EBIT year-on-year change?
- What is BioNTech SE TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BioNTech SE?
- What is BioNTech SE TTM EBIT year-on-year change?
What is BioNTech SE annual earnings before interest & taxes?
The current annual EBIT of BNTX is $978.90 M
What is the all time high annual EBIT for BioNTech SE?
BioNTech SE all-time high annual earnings before interest & taxes is $17.75 B
What is BioNTech SE quarterly earnings before interest & taxes?
The current quarterly EBIT of BNTX is $183.34 M
What is the all time high quarterly EBIT for BioNTech SE?
BioNTech SE all-time high quarterly earnings before interest & taxes is $5.64 B
What is BioNTech SE quarterly EBIT year-on-year change?
Over the past year, BNTX quarterly earnings before interest & taxes has changed by -$222.44 M (-54.82%)
What is BioNTech SE TTM earnings before interest & taxes?
The current TTM EBIT of BNTX is -$625.96 M
What is the all time high TTM EBIT for BioNTech SE?
BioNTech SE all-time high TTM earnings before interest & taxes is $21.24 B
What is BioNTech SE TTM EBIT year-on-year change?
Over the past year, BNTX TTM earnings before interest & taxes has changed by -$1.62 B (-162.68%)